Your browser doesn't support javascript.
loading
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia.
Wu, Qian; Yang, Xiaofei; Zhang, Jingren; Xue, Mengxing; Dou, Xueqing; Ge, Zheng; Chen, Yifei; Gu, Weiying; Dong, Weimin; Cao, Hongying; Jiang, Naike; Sun, Xuemei; Liu, Zefa; Shi, Jinning; Chen, Hui; Zhang, Cixian; Min, Fengling; Sun, Hongli; Qian, Xiaoli; Yuan, Hongjian; Feng, Yuan; Wu, De-Pei; Chen, Suning.
Afiliación
  • Wu Q; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
  • Yang X; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Zhang J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
  • Xue M; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Dou X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
  • Ge Z; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Chen Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
  • Gu W; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Dong W; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
  • Cao H; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Jiang N; Zhongda Hospital Southeast University, Nanjing, PR China.
  • Sun X; Jiangdu People's Hospital of Yangzhou, Yangzhou, PR China.
  • Liu Z; The First People's Hospital of Changzhou, Changzhou, PR China.
  • Shi J; The First People's Hospital of Changzhou, Changzhou, PR China.
  • Chen H; Changzhou No.2 People's Hospital, Changzhou, PR China.
  • Zhang C; Changzhou No.2 People's Hospital, Changzhou, PR China.
  • Min F; Jiangsu Province Hospital of Chinese Medicine, Nanjing, PR China.
  • Sun H; Xinghua City People's Hospital, Taizhou, PR China.
  • Qian X; The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, PR China.
  • Yuan H; Yancheng NO.1 People's Hospital, Yancheng, PR China.
  • Feng Y; Xuzhou Central Hospital, Xuzhou, PR China.
  • Wu DP; Affiliated Hospital of Yangzhou University, Yangzhou, PR China.
  • Chen S; Wuxi People's Hospital, Wuxi, PR China.
Blood Cancer J ; 14(1): 113, 2024 Jul 15.
Article en En | MEDLINE | ID: mdl-39009567
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article